INDV vs LIN · P/E 19, rev $1.19B vs P/E 34, rev $33.99B
Indivior PLC Ordinary Shares (INDV) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported INDV revenue for 2024-12-31 was $1.19B. Net income was $2.0M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. INDV currently screens at market cap $4.48B and trailing P/E 19.5.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
INDV currently screens at market cap $4.48B and trailing P/E 19.5. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the INDV and LIN stock pages for the full models.
Not investment advice.